[go: up one dir, main page]

HK40115056A - Compositions and methods for the treatment of proteopathies - Google Patents

Compositions and methods for the treatment of proteopathies Download PDF

Info

Publication number
HK40115056A
HK40115056A HK62025103064.4A HK62025103064A HK40115056A HK 40115056 A HK40115056 A HK 40115056A HK 62025103064 A HK62025103064 A HK 62025103064A HK 40115056 A HK40115056 A HK 40115056A
Authority
HK
Hong Kong
Prior art keywords
proteopathies
compositions
treatment
methods
Prior art date
Application number
HK62025103064.4A
Other languages
Chinese (zh)
Inventor
Akinori HISHIYA
Keizo Koya
Original Assignee
Sola Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sola Biosciences Llc filed Critical Sola Biosciences Llc
Publication of HK40115056A publication Critical patent/HK40115056A/en

Links

HK62025103064.4A 2021-10-08 2022-10-07 Compositions and methods for the treatment of proteopathies HK40115056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/253,767 2021-10-08

Publications (1)

Publication Number Publication Date
HK40115056A true HK40115056A (en) 2025-03-21

Family

ID=

Similar Documents

Publication Publication Date Title
IL308221A (en) Compositions and methods for the treatment of depression
EP4319741A4 (en) Compositions and methods for the treatment of cancer
EP4225923A4 (en) Compositions and methods for the prevention and/or treatment of covid-19
EP4110369A4 (en) Methods of treatment and related compositions
EP4055040A4 (en) Compositions and methods for treatment of cancer with lekti
EP4161925A4 (en) Compositions and methods for the treatment of liver disorders
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4168425A4 (en) Methods and compositions for the treatment of muscular dystrophy
EP3999851A4 (en) Compositions and methods for the treatment of tuberculosis
EP4216938A4 (en) Compositions and methods for the treatment of hair loss and other conditions
EP4025258A4 (en) Methods and compositions for the treatment of als
EP4175978A4 (en) Compositions and methods for treating crp-mediated diseases
HK40115056A (en) Compositions and methods for the treatment of proteopathies
HK40090686A (en) Methods and compositions for the treatment of sars-cov-2
HK40107055A (en) Compositions and methods for the treatment of depression
HK40117352A (en) Methods and compositions for the treatment of cancer
HK40102245A (en) Dsg2 compositions and methods for the treatment of covid-19
HK40115072A (en) Compositions and methods for the treatment of pcdh19 related disorders
HK40104867A (en) Compositions and methods useful for the treatment of h-abc leukodystrophy
HK40118268A (en) Compositions and methods for the treatment of depression
HK40120077A (en) Compositions and methods for the treatment of depression
HK40119000A (en) Compositions and methods for the treatment of depression
AU2020901796A0 (en) Compositions and methods for treatment
AU2020902478A0 (en) Compositions and methods for the treatment of cancer
HK40089060A (en) Compositions and methods for the treatment of synucleinopathies